Skip to main content
. 2011 May 1;21(1):1511–15146. doi: 10.1002/9780471729259.mc15e01s21

Table 4.

Seven Plasmids for MHV‐A59‐1000, Their Backbones, Antibiotic Resistance, and Restriction Enzymes Used

Plasmid name

Vector backbone

Antibiotic resistance

Vector fragment (kpb)

Insert size (kpb)

RE to excise fragment

A

PCR‐XL‐TOPO (Invitrogen)

Kanamycin 30 µg/ml

3.5

4.9

MluI × BsmBI

B

pSMART‐LC (Lucigen)

Ampicillin 50 µg/ml

1.2 + 0.8

4.7

BglI × BsmBI

C

pSMART‐LC (Lucigen)

Ampicillin 50 µg/ml

1.2 + 1.5

2.0

BglI × BsmBI

D

pSMART‐LC (Lucigen)

Ampicillin 50 µg/ml

1.0 + 1.0

1.45

AhdI × BsmBI

E

pSMART‐LC (Lucigen)

Ampicillin 50 µg/ml

1.2 + 0.8

2.8

BglI × BsmBI

F

PCR‐XL‐TOPO (Invitrogen)

Kanamycin 30 µg/ml

3.5

7.0

BsmBI

G

pBR322

Ampicillin 50 µg/ml

2.2 + 2.1

8.7

SfiI × BsmBI

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.